Clinical Trial Update: An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial of CC-10004 for chronic prostatitis/chronic pelvic pain syndrome has completed and its results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatitis Chronic Pelvic Pain Syndrome

Drugs mentioned

• CC-10004

Snippet

Sponsor: Kenneth Peters, MD | Conditions: Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-05-16